{"database": "openregs", "table": "documents", "rows": [["FDA-2024-D-5601-0016", "FDA", "FDA-2024-D-5601", "E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft Guidance for Industry; Reopening of the Comment Period", "Notice", "Extension of Comment Period", "2025-03-13T04:00:00Z", 2025, 3, "2025-03-13T04:00:00Z", null, "2025-03-13T13:11:09Z", "2025-04026", 0, 0, "09000064869e6d90"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2024-D-5601-0016"], "units": {}, "query_ms": 119.07734209671617, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}